// App-Quantinova.ai

8569 : A real-world experience of nivolumab in advanced malignant mesothelioma (MM).

Researchers

Presenter

  • Hussein Hamad

Principal Investigators

  • Sumaira Shafi

  • Veronica Lenge De Rosen

  • Jun Zhang

Medical Centers

  • Baylor College of Medicine, Houston, TX

  • Baylor College of Medicine, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • Nivolumab

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved